Nodular Amyloidosis
Nodular amyloidosis (NA) is the rarest form of primary localized cutaneous amyloidosis, but also the most dangerous and the one with the most serious clinical implications.
The more common forms of cutaneous amyloidosis (macular, lichen, and biphasic) are made of degraded epidermal keratin (amyloid K). Nodular amyloidosis is entirely different: it is made of immunoglobulin light chains (kappa or lambda) secreted by plasma cells infiltrating the skin (amyloid AL). It appears as single or scattered nodules with a smooth, shiny, slightly atrophic surface and a pinkish-gray or yellow-brown color.
Importantly, nodular amyloidosis is regarded as a "sentinel" skin sign: about 7–15% of patients with cutaneous NA go on to develop systemic AL amyloidosis or turn out to have an underlying plasma cell disorder of the bone marrow (such as multiple myeloma). At Haute-Derma, caring for a patient with NA means rigorous systemic screening alongside treatment to remove the skin lesions.
Pathophysiology
At the molecular level, nodular amyloidosis works quite differently from the other forms of primary cutaneous amyloidosis (PCA):
- AL Amyloid Origin: The amyloid does not come from keratinocytes damaged by scratching. Instead, a clonal population of plasma cells in the dermis and subcutis secretes kappa or lambda light chains, which misfold and form AL amyloid fibrils.
- Deep, Full-Thickness Infiltration: AL amyloid fibrils are deposited from the papillary dermis down into the deep dermis and subcutaneous fat, and invade the walls of skin blood vessels as well as the areas around sweat glands and hair follicles.
- Vascular Complications: Amyloid deposits make vessel walls thin, brittle, and stiff. Even minor trauma can rupture them, causing congestion, petechiae, or patches of bleeding (purpura) right on the surface of the nodule.
Clinical Features and Warning Signs
Clinical Appearance
- Primary Lesions: Firm, infiltrated nodules, papules, or plaques ranging from a few millimeters to several centimeters.
- Surface and Color: The surface is smooth and shiny, sometimes slightly atrophic or with visible small vessels (telangiectasia). Typical colors are pinkish-gray, reddish-brown, or waxy yellow.
- Symptoms: Unlike lichen or macular amyloidosis, nodular amyloidosis is usually NOT itchy and not painful (unless it presses on a nerve or ulcerates).
- Common Sites: The face, arms and legs, trunk, scalp, and genital area. It can also affect mucous membranes (the tongue and lining of the mouth).
Associated Bleeding (Purpuric Signs)
- The surface of the nodule bleeds easily, either spontaneously or after a light knock.
- Bruise-like bleeding over a waxy yellow nodule strongly suggests amyloid deposited around blood vessels.
Screening and Diagnosis at Haute-Derma
When nodular amyloidosis is suspected, our first priority at Haute-Derma is not cosmetic treatment of the skin but ruling out systemic AL amyloidosis.
Histopathologic Biopsy and Immunofluorescence
- H&E staining: Pale pink amorphous material fills the dermis and subcutis and surrounds blood vessels and skin appendages, with infiltrating plasma cells nearby.
- Congo red staining: Shows apple-green birefringence under polarized light.
- Immunohistochemistry (IHC): Shows whether kappa or lambda light chains predominate, confirming the AL nature of the deposits.
Tests to Rule Out Systemic Involvement
- Serum free light chains (sFLC): Measures the kappa/lambda ratio. A markedly abnormal ratio raises suspicion of a systemic plasma cell neoplasm.
- Immunofixation electrophoresis (IFE): Looks for a monoclonal spike (M-protein) in the blood and urine.
- Echocardiography and cardiac biomarkers: NT-proBNP and troponin are checked to rule out amyloid deposits in the heart muscle (which cause heart failure with a thickened heart wall).
- 24-hour urine protein: Assesses for nephrotic syndrome caused by amyloid in the glomeruli.
Treatment of Nodular Amyloidosis at Haute-Derma
Managing the Skin Lesions
If the nodular amyloidosis is confirmed to be limited to the skin (no internal organ involvement):
- Surgical Excision: The first choice for single, moderately sized nodules. Wide margins are needed because the amyloid infiltrates deeply, yet local recurrence still occurs in 20–40% of cases.
- Liquid Nitrogen Cryosurgery (Cryotherapy): Used for small scattered nodules. Freezing the lesion with liquid nitrogen destroys the amyloid tissue and the local plasma cells.
- Ablative CO2 Laser Resurfacing: CO2 laser energy removes the nodule layer by layer, flattening lesions on the face or scalp.
- Intralesional Corticosteroid / Triamcinolone (TAC) Injections: Reduce the inflammatory infiltrate and shrink the nodule.
Management of Systemic Progression (Systemic AL)
If the disease progresses to systemic amyloidosis or is linked to multiple myeloma, skin treatment plays only a supporting role. The patient must be referred to Hematology-Oncology for systemic therapy:
- Monoclonal Antibody Therapy: daratumumab (an antibody against CD38 on the surface of plasma cells) combined with CyBorD (cyclophosphamide + bortezomib + dexamethasone).
- Autologous Stem Cell Transplantation (ASCT): For patients fit enough to undergo it, with the aim of eradicating the abnormal plasma cell clone.
